Within the controlled environments of Britain’s leading academic institutes, biotechnology incubators, and independent commercial labs, a quiet but profound revolution continues to unfold. Short chains of amino acids—known as peptides—are reshaping how we understand cellular communication, disease mechanisms, and biomaterial engineering. For UK-based researchers, the journey from hypothesis to publication hinges on one critical variable:…